
Elon Musk’s brain implant company Neuralink received the green light from the United States’ Food and Drug Administration (FDA) to conduct clinical trials in humans, according to an announcement posted to Neuralink’s Twitter account on May 25. The company hasn’t started recruiting participants yet but claimed it will announce more details soon.